HyperVAX+Staph A vaccine data

UNVX presented data on its prototype vaccine directed at Type 5 Staph A, showing that sera, as well as purified antibodies, from vaccinated patients helped kill the bacteria. Phase I results were presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy in New Orleans, showing that all 180 vaccinated patients produced killing antibodies against the bacteria. ...